Clinical Trial Update: Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Fiber Neuropathy

Drugs mentioned

• Lacosamide (Lacosamide)

Snippet

Sponsor: Academisch Ziekenhuis Maastricht | Conditions: Small Fiber Neuropathy | Phase 3 | Status: COMPLETED